7 completed, 1 active not recruiting. 4 Phase 1, 2 Early Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
| Early Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Latigo Biotherapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants LTG-001 SDD, LTG-001 Formulation A Prototype 1, LTG-001 Formulation B Prototype 2 - Pain Management | Phase 1 | Completed | Latigo Biotherapeutics | 14 | 2025-10-06 | 2026-01-14 |
| Phase 1 Single and Multiple Ascending Dose of LTG-321 in Healthy Participants LTG-321, Placebo - Healthy Participants | Phase 1 | Completed | Latigo Biotherapeutics | 112 | 2025-09-03 | 2026-06-29 |
| An Efficacy and Safety Study of LTG-001 Following Abdominoplasty Experimental: LTG-001 High Dose, Experimental: LTG-001 Low Dose, Active Comparator: HB/APAP - Acute Pain, Postoperative Pain Control | Phase 2 | Completed | Latigo Biotherapeutics | 343 | 2025-07-24 | 2026-04-29 |
| Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults suzetrigine 100mg, Placebo - Pain Detection, Pain Threshold | Early Phase 1 | Completed | Latigo Biotherapeutics | 20 | 2025-06-04 | 2025-07-03 |
| This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars LTG-001 High Dose, LTG-001 Mid Dose, LTG-001 Low Dose - Acute Pain, Postoperative | Phase 2 | Completed | Latigo Biotherapeutics | 250 | 2024-12-19 | 2026-05-22 |
| Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults pregabalin 300 mg, Placebo - Pain Detection, Pain Threshold | Early Phase 1 | Completed | Latigo Biotherapeutics | 20 | 2024-10-07 | 2025-05-04 |
| A Phase 1 Single and Multiple Ascending Dose Study of LTG-305 Administered Orally in Healthy Participants LTG-305 - Healthy | Phase 1 | Completed | Latigo Biotherapeutics | 112 | 2024-09-03 | 2025-07-04 |
| A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants LTG-001, Placebo - Healthy | Phase 1 | Active not recruiting | Latigo Biotherapeutics | 204 | 2023-10-17 | 2026-06-16 |
Acute Pain (2) · Agnosia (1) · Pain, Postoperative (1)
Pregabalin (1)
New Zealand (5) · United States (3)